EDBLW

EDBLW
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.817M ▼ | $3.831M ▼ | $-4.045M ▼ | -143.592% ▼ | $-1.38 ▲ | $-2.544M ▲ |
| Q2-2025 | $3.146M ▲ | $4.227M ▲ | $-4.043M ▼ | -128.512% ▼ | $-6.58 ▼ | $-3.219M ▼ |
| Q1-2025 | $2.718M ▼ | $3.014M ▲ | $-3.324M ▼ | -122.296% ▼ | $-2.47 ▼ | $-2.583M ▲ |
| Q4-2024 | $3.872M ▲ | $2.764M ▲ | $-3.079M ▼ | -79.52% ▲ | $-2.2 ▼ | $-3.083M ▼ |
| Q3-2024 | $2.584M | $2.189M | $-2.063M | -79.837% | $-0.65 | $-1.409M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $828K ▼ | $20.132M ▼ | $7.209M ▲ | $12.923M ▼ |
| Q2-2025 | $2.821M ▲ | $21.814M ▲ | $5.222M ▼ | $16.592M ▲ |
| Q1-2025 | $409K ▼ | $8.535M ▼ | $6.617M ▼ | $1.918M ▼ |
| Q4-2024 | $3.53M ▲ | $11.915M ▲ | $7.821M ▲ | $4.094M ▲ |
| Q3-2024 | $2.214M | $8.863M | $5.604M | $3.259M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-4.045M ▼ | $-2.378M ▲ | $-409K ▼ | $794K ▼ | $-1.993M ▼ | $-2.787M ▲ |
| Q2-2025 | $-4.043M ▼ | $-3.432M ▼ | $-54K ▲ | $5.898M ▲ | $2.412M ▲ | $-3.486M ▼ |
| Q1-2025 | $-3.324M ▼ | $-3.332M ▼ | $-68K ▲ | $279K ▼ | $-3.121M ▼ | $-3.411M ▼ |
| Q4-2024 | $-3.079M ▼ | $-1.755M ▼ | $-126K ▼ | $3.197M ▲ | $1.316M ▲ | $-1.881M ▼ |
| Q3-2024 | $-2.063M | $-1.112M | $-10K | $1.148M | $26K | $-1.122M |
Revenue by Products
| Product | Q2-2024 | Q3-2024 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Vitamins and Supplements | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, this looks like an innovation-heavy, early-stage agricultural and food platform that has not yet proven its financial durability. The strategy leans on sustainability, technology, and a broader product mix, including higher-margin consumer packaged goods, all of which could improve economics over time if successfully scaled. At the same time, the historical numbers show a business with minimal revenue, ongoing losses, weak cash generation, and a very light balance sheet. The main uncertainties center on the path to sustainable profitability, the ability to maintain and expand retail partnerships, the integration of new technologies like aquaculture, and access to capital if the current loss profile persists.
About Edible Garden AG Incorporated
https://www.ediblegarden.comEdible Garden AG Incorporated and its subsidiaries operate as a controlled environment agriculture farming company. It offers various products, including individually potted, live herbs, cut single-herb clamshells, specialty herb items, various types of lettuce, hydro basil, bulk basil, and vegan protein powder. The company sells its products to various regional and national supermarkets.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.817M ▼ | $3.831M ▼ | $-4.045M ▼ | -143.592% ▼ | $-1.38 ▲ | $-2.544M ▲ |
| Q2-2025 | $3.146M ▲ | $4.227M ▲ | $-4.043M ▼ | -128.512% ▼ | $-6.58 ▼ | $-3.219M ▼ |
| Q1-2025 | $2.718M ▼ | $3.014M ▲ | $-3.324M ▼ | -122.296% ▼ | $-2.47 ▼ | $-2.583M ▲ |
| Q4-2024 | $3.872M ▲ | $2.764M ▲ | $-3.079M ▼ | -79.52% ▲ | $-2.2 ▼ | $-3.083M ▼ |
| Q3-2024 | $2.584M | $2.189M | $-2.063M | -79.837% | $-0.65 | $-1.409M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $828K ▼ | $20.132M ▼ | $7.209M ▲ | $12.923M ▼ |
| Q2-2025 | $2.821M ▲ | $21.814M ▲ | $5.222M ▼ | $16.592M ▲ |
| Q1-2025 | $409K ▼ | $8.535M ▼ | $6.617M ▼ | $1.918M ▼ |
| Q4-2024 | $3.53M ▲ | $11.915M ▲ | $7.821M ▲ | $4.094M ▲ |
| Q3-2024 | $2.214M | $8.863M | $5.604M | $3.259M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-4.045M ▼ | $-2.378M ▲ | $-409K ▼ | $794K ▼ | $-1.993M ▼ | $-2.787M ▲ |
| Q2-2025 | $-4.043M ▼ | $-3.432M ▼ | $-54K ▲ | $5.898M ▲ | $2.412M ▲ | $-3.486M ▼ |
| Q1-2025 | $-3.324M ▼ | $-3.332M ▼ | $-68K ▲ | $279K ▼ | $-3.121M ▼ | $-3.411M ▼ |
| Q4-2024 | $-3.079M ▼ | $-1.755M ▼ | $-126K ▼ | $3.197M ▲ | $1.316M ▲ | $-1.881M ▼ |
| Q3-2024 | $-2.063M | $-1.112M | $-10K | $1.148M | $26K | $-1.122M |
Revenue by Products
| Product | Q2-2024 | Q3-2024 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Vitamins and Supplements | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, this looks like an innovation-heavy, early-stage agricultural and food platform that has not yet proven its financial durability. The strategy leans on sustainability, technology, and a broader product mix, including higher-margin consumer packaged goods, all of which could improve economics over time if successfully scaled. At the same time, the historical numbers show a business with minimal revenue, ongoing losses, weak cash generation, and a very light balance sheet. The main uncertainties center on the path to sustainable profitability, the ability to maintain and expand retail partnerships, the integration of new technologies like aquaculture, and access to capital if the current loss profile persists.

CEO
James E. Kras
Compensation Summary
(Year 2024)

CEO
James E. Kras
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : C
Institutional Ownership

ARENA INVESTORS LP
220K Shares
$31.812K

BARD ASSOCIATES INC
144.525K Shares
$20.898K

HUDSON BAY CAPITAL MANAGEMENT LP
100K Shares
$14.46K

ANSON FUNDS MANAGEMENT LP
50K Shares
$7.23K

CLEAR STREET LLC
17.067K Shares
$2.468K

CLEAR STREET GROUP INC.
16.567K Shares
$2.396K

COSTON, MCISAAC & PARTNERS
1.4K Shares
$202.44

UBS GROUP AG
134 Shares
$19.376

CONCOURSE FINANCIAL GROUP SECURITIES, INC.
0 Shares
$0
Summary
Only Showing The Top 9

